A company using an expensive two stage assembly for a cartridge used to contain their drug compound asked Sovrin to devise a one piece answer to improve the storage life of the product whilst offering a cost reduction.
Injection Moulding specialists, Sovrin Plastics have signed an agreement for the construction of a new 43,000 sq. ft.(4000 sqm) manufacturing facility to house its Tooling, Class 8 & GMP cleanroom moulding and assembly divisions.
The new, state of the art facility represents a £4.5 million investment in Sovrin’s future and will feature some of the latest injection moulding, automation and material handling technology.
With a focus on lean manufacturing and 50 years of technical injection moulding and assembly expertise, Sovrin have designed the new manufacturing site to improve utilisation and efficiency whilst significantly reducing its carbon footprint. This development exemplifies Sovrin’s policy of continuous investment for the future, constantly enhancing our capabilities and supporting our developing customer base in whatever way possible.
Construction is underway on a brownfield site, close to their existing manufacturing sites which will ease the transfer into the new building to be completed by the Autum of 2015. The current Class 7 cleanroom moulding, assembly and medical device manufacturing which neighbours the new build will be retained.
Total Area 4,137 sqm (44,530 sq. ft.)
ISO 8 and Clean area
Assembly clean area - 648 sqm
Moulding clean area - 545 sqm
Moulding area ISO Class 8 - 315 sqm
Moulding area ISO Class 7 - 400 sqm at existing facility
Assembly area ISO Class 7 - 300 sqm at existing facility
Injection moulding machines - 28 with robotic handling
A total of 42 injection moulding machines from 5 to 350T
Space for 4/5 automated assembly cells
235 sqm avalaible for future projects
On site mould tool manufacture and maintenance
If you require any additional information about out new facility or have a project that requires a dedicated manufacturing cell, please do not hesitate to contact us.